Skip to content

Genetic screening and treatment follow-up of hypophosphatemic rickets caused by PHEX gene mutation

Genetic screening and treatment follow-up of hypophosphatemic rickets caused by PHEX gene mutation

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018018
Enrollment
Unknown
Registered
2018-08-27
Start date
2018-10-30
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypophosphatemic rickets caused by PHEX gene mutation

Interventions

Sponsors

Shanghai Jiaotong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients with the definite diagnosis of hypophosphatemic rickets confirmed by genetic screening, and the age was <18 years old or the epiphysis was not closed; 2. signing the informed consent form in person by the patients or his family members, indicating that the patients has been informed of all the relevant research contents; 3. patients and their families are willing and able to cooperate with research-related medical history collection, full examination, intervention treatment and other research procedures.

Exclusion criteria

Exclusion criteria: 1. other inherited skeletal dysplasias identified with other gene mutations through genetic screenin; 2. rickets caused by nutritional deficiency, such as vitamin D intake insufficiency, absorption and metabolic disorders; 3. long-term use of drugs that affect bone metabolism, such as glucocorticoids, adrenaline or synthetic steroids, anticonvulsants; 4. patients with other serious diseases, such as osteosarcoma, malignant hematologic diseases; 5. other causes of abnormal bone metabolism, such as metal poisoning, high-fluoride intake; 6. other causes of osteopathy, such as trauma, long-term immobilization; 7. patients the researchers believe should not participate in the test.

Design outcomes

Primary

MeasureTime frame
Growth index assessment;Bone disease assessment;Biochemical detection index;X-ray film;bone mineral density;

Countries

China

Contacts

Public ContactZhenlin Zhang

Shanghai Jiaotong University Affiliated Sixth People's Hospital

zhangzl@sjtu.edu.cn+86 13621673716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026